Pear Therapeutics Investor Relations Material
Latest events
Q3 2022
Pear Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pear Therapeutics Inc
Access all reports
Pear Therapeutics Inc. is a healthcare company specializing in the development and commercialization of digital therapeutics. These software-based treatments are designed to address a range of medical conditions by delivering clinically validated behavioral therapies through mobile and desktop applications. Pear’s products target areas such as substance use disorder, insomnia, and mental health, aiming to provide personalized, evidence-based care to patients. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PEAR
Country
🇺🇸 United States